Drone & Defense Scan
Drone & Defense Scan
This remains the weakest book in the batch, and the horizon check got worse, not better — 15 of 21 names lost RSI ground this cycle, and 14 of 21 now carry a negative alpha1y, up from roughly half last scan. AeroVironment reported a genuine Q1 FY27 beat-and-raise on September 10 (funded backlog up 37% to $1.5B) and gained RSI on it, but the stock remains 30% below its 200-day and negative on both the trailing year and alpha — a real catalyst inside a still-broken chart. Planet Labs is the weakest reading in the entire book at RSI 23.5, down further from last cycle's 28.6, despite its own Q2 beat — soft Q3 guidance and a 28%+ analyst price-target cut are the confirmed drag.
Data as-of the 2026-09-11 close for 20 of 21 names; AVEX carries no 200-day comparison (too-young regime). DFEN was removed from this book on September 8 under the desk's leveraged/inverse-ETF avoid policy — a policy retirement, not a trading signal. Comparison baseline is the September 4 scan.
Quick Snapshot
| Signal | Reading |
|---|---|
| Overall | 🔴 15 of 21 names lost RSI this cycle; 14 of 21 now carry a negative alpha1y — the negative-alpha share widened from last cycle, not narrowed |
| Leaders | DPRO (RSI 58.3, though its own alpha1y is now confirmed negative at -4.69), MSI (50.2, also negative alpha1y), EOPSF (50.0, research-only) |
| Laggards | PL (RSI 23.5, thesis rated broken, weakest reading in the book) and ITA (28.5), KRKNF (28.6, research-only) hold the lowest readings |
| The real split | Only 6 of 21 names (EOPSF, UMAC, ESLT, LASR, RTX, PL) carry a positive alpha1y despite this cycle's collapse-tagged regimes — that group is a genuine pullback-inside-a-trend; the other 14 are the durable warning |
What's Going On
This book moved against the tape again — 15 of 21 names lost RSI ground this cycle, the same direction as last scan's uniformly weak reading, though this time it's less universal (6 gainers versus none last cycle). The horizon check is the more important shift: 14 of 21 names now carry a negative alpha1y, up from roughly half the book last cycle. That includes names whose headline 1-year return still looks intact — TDY (+6.66% 1y but -9.56 alpha), LMT (+11.36% 1y but -4.86 alpha), ITA (+9.47% 1y but -6.75 alpha) — real underperformance sitting behind a chart that reads flat rather than broken. Sixteen of 21 names sit below their 200-day.
AeroVironment is the session's clearest real catalyst. Its news receipt (fetched September 11, newest article September 10) reports Q1 FY27 results beating expectations, with funded backlog up 37% to $1.5B, total backlog $2.8B, and a raised FY27 revenue outlook — the stock reportedly rose roughly 6.9% premarket on the print. RSI gained 4.4 points this cycle (38.9 → 43.3) on 2.46x average volume, a real volume-confirmed move. But the stock remains 30.1% below its 200-day, down 39.33% over the trailing year with an alpha1y of -55.55 — a genuine positive catalyst landing inside a chart that hasn't turned.
Planet Labs is the mirror case. Its own news receipt (fetched September 11) describes the stock's reaction to soft Q3 guidance and a 28%+ analyst price-target cut following what the same receipt separately confirms was a record-revenue Q2 print (raised FY2027 guidance to $430-441M). Despite that beat, RSI fell further this cycle — 28.6 → 23.5, now the weakest reading in the entire book — and PL sits 39.3% below its 200-day. The desk's own thesis rating for PL remains "broken." This is the sharpest beat-versus-tape disconnect in the book, confirmed by name this cycle rather than left open.
DPRO continues to lead the book on RSI (58.3) but gave back 11.3 points this cycle after last scan's unexplained 20-point surge, and its alpha1y now reads -4.69 — the long-horizon check does not back up the recent rally. MSI's own trailing year stays negative (-4.92%) with the most negative alpha1y in the book's upper tier (-21.14) despite still holding the second-highest RSI.
What Changed Since September 4
- DFEN removed from this book entirely on September 8 — leveraged/inverse ETF avoid-list policy, not a trading signal.
- AVAV: RSI 38.9 → 43.3 (+4.4), the largest gain in the book, confirmed by a real Q1 FY27 beat-and-raise (2.46x average volume) — still 30.1% below its 200-day.
- ESLT: RSI 33.2 → 44.7 (+11.5), the single largest RSI move in the book this cycle; no confirmed catalyst has been checked for the size of this move.
- DPRO: RSI 69.6 → 58.3 (-11.3), giving back most of last cycle's unexplained surge; alpha1y now confirmed negative.
- PL: RSI 28.6 → 23.5 (-5.1), now the weakest reading in the book; soft Q3 guidance and a 28%+ analyst price-target cut confirmed as the drag despite the underlying Q2 beat.
- KRKNF: RSI 33.6 → 28.6 (-5.0); ITA: RSI 33.4 → 28.5 (-4.9); AXON: RSI 40.7 → 35.9 (-4.8).
- EOPSF: RSI 54.2 → 50.0 (-4.2); ONDS: RSI 43.4 → 39.5 (-3.9); RCAT: RSI 43.0 → 40.1 (-2.9); AMPX: RSI 43.1 → 40.3 (-2.8).
- The negative-alpha1y group widened from roughly half the book last cycle to 14 of 21 names this cycle.
How To Read The Board
The horizon check for this book is deteriorating, not stabilizing — more names now show a negative alpha1y than last cycle, including some (TDY, LMT, ITA) whose headline 1-year return still looks flat-to-positive. Only six names — EOPSF, UMAC, ESLT, LASR, RTX, PL — carry a positive alpha1y despite this cycle's weak regime tags, and even PL's positive alpha1y sits against a desk thesis rating of "broken" and this cycle's weakest RSI in the book, so that name shouldn't be read as reassuring. AVAV's real earnings beat is the session's genuine positive catalyst, but it lands inside a chart that is still 30% below its 200-day and negative on both the trailing year and alpha — a catalyst, not yet a turn.
Price Table
| Stock | Price | RSI | SMA20 | vs SMA | 7D% | 30D% | Signal |
|---|---|---|---|---|---|---|---|
| DPRO | $5.61 | 58.3 | $5.05 | +11.1% | -8.33% | +22.76% | downtrend (below 200-day, alpha1y -4.69) |
| MSI | $466.16 | 50.2 | $475.17 | -1.9% | -0.4% | -0.76% | uptrend (1y and alpha both negative) |
| EOPSF | $6.40 | 50.0 | $6.58 | -2.7% | -3.76% | +7.2% | pullback (research-only, thesis: unrated) |
| UMAC | $22.95 | 45.9 | $25.73 | -10.8% | -3.41% | -15.09% | pullback |
| ESLT | $728.00 | 44.7 | $729.99 | -0.3% | +3.51% | -6.61% | pullback (largest single-cycle RSI move, unconfirmed cause) |
| AVAV | $146.71 | 43.3 | $154.83 | -5.2% | +1.42% | -24.3% | collapse (below 200-day; Q1 FY27 beat-and-raise confirmed) |
| AVEX | $16.08 | 41.0 | $17.79 | -9.6% | -2.37% | -29.32% | too-young |
| AMPX | $9.44 | 40.3 | $10.21 | -7.6% | -4.55% | -22.88% | collapse (below 200-day, alpha1y -0.25) |
| RCAT | $7.96 | 40.1 | $9.02 | -11.8% | -4.9% | -22.87% | collapse (negative 1y and alpha) |
| ONDS | $7.23 | 39.5 | $8.08 | -10.5% | -5.12% | -26.0% | collapse (below 200-day, alpha1y -3.6) |
| DRSHF | $1.21 | 39.1 | $1.30 | -7.2% | -3.97% | -17.12% | collapse (research-only, negative 1y and alpha) |
| NOCE | $518.97 | 37.6 | $544.36 | -4.7% | +0.77% | -10.11% | downtrend (negative 1y and alpha) |
| LMT | $524.19 | 36.9 | $558.01 | -6.1% | -0.21% | -13.6% | pullback (alpha1y negative despite positive 1y) |
| LASR | $40.37 | 36.4 | $44.19 | -8.6% | +0.77% | -23.89% | collapse (thesis: intact, alpha1y +22.22) |
| AXON | $479.34 | 35.9 | $567.71 | -15.6% | -7.05% | -20.08% | downtrend (negative 1y and alpha) |
| TDY | $603.79 | 35.5 | $626.19 | -3.6% | -1.12% | -12.05% | basing (alpha1y negative despite positive 1y) |
| KTOS | $46.69 | 34.5 | $53.04 | -12.0% | -2.36% | -26.84% | collapse (negative 1y and alpha) |
| RTXE | $197.68 | 32.1 | $208.83 | -5.3% | -1.55% | -11.26% | pullback (alpha1y +9.17) |
| KRKNF | $3.30 | 28.6 | $3.96 | -16.8% | -11.05% | -30.53% | collapse (research-only, negative 1y and alpha) |
| ITA | $219.01 | 28.5 | $232.89 | -6.0% | -2.93% | -12.96% | basing (alpha1y negative despite positive 1y) |
| PL | $16.45 | 23.5 | $20.43 | -19.5% | -9.22% | -32.86% | collapse (below 200-day; Q2 beat, soft Q3 guidance and price-target cut confirmed; thesis: broken; weakest in book) |
Tier Analysis
Tier A — RSI 45+ (5): DPRO (alpha now negative), MSI (1y and alpha both negative), EOPSF (research-only), UMAC, ESLT (unconfirmed cause for the cycle's largest move).
Tier B — Mid-book, RSI 35-45 (10): AVAV (real catalyst, still deeply below 200-day), AVEX (too-young), AMPX, RCAT, ONDS, DRSHF (research-only), NOC, LMT, LASR (thesis intact), AXON.
Tier C — Weakest, RSI <35 (6): TDY, KTOS, RTX, KRKNF (research-only), ITA, PL (thesis broken, weakest reading).
Entry Zones
| Stock | Price | RSI | 30D% | Setup |
|---|---|---|---|---|
| AVAV | $146.71 | 43.3 | -24.3% | Confirmed Q1 FY27 beat-and-raise on real volume, but still 30.1% below its 200-day and negative on trailing-year and alpha — a real catalyst, not yet a confirmed turn |
| LASR | $40.37 | 36.4 | -23.89% | Thesis rated intact by the desk with a positive alpha1y (+22.22) despite this cycle's collapse tag |
| RTXE | $197.68 | 32.1 | -11.26% | One of only six names in the book with a positive alpha1y; lowest RSI among that group |
Action Matrix
| Action | Stocks | Why |
|---|---|---|
| 🔍 RESEARCH | AVAV | Confirmed real earnings beat and raise, but the chart remains deeply damaged — worth confirming the technical follow-through |
| ⚠️ AVOID | MSI, AMPX, RCAT, ONDS, DRSHF, NOC, AXON, KTOS, KRKNF | All carry a negative alpha1y this cycle — the widening group, not the shrinking one |
| 🔍 WATCH | TDY, LMT, ITA | Headline 1-year return still positive, but alpha1y is negative in all three — underperformance hiding behind a flat-looking chart |
| ❌ DON'T BUY | PL | Thesis rated broken by the desk; weakest RSI in the book despite a confirmed underlying earnings beat |
| 🔍 RESEARCH | ESLT, LASR, UMAC, EOPSF | Positive alpha1y despite this cycle's weak regime tags — the smaller group of names reading as pullback, not breakdown |
| 🔍 DATA CAVEAT | AVEX | Too-young regime; no 200-day or trailing-year comparison available yet |
What To Watch Next
| Watch | Why it matters |
|---|---|
| Whether AVAV's real catalyst produces a technical turn | Confirmed beat-and-raise on real volume, but still 30% below its 200-day |
| PL's response to the soft Q3 guidance | Now the weakest reading in the entire book despite an underlying Q2 beat — the guidance cut is the confirmed near-term driver |
| Whether the negative-alpha group keeps widening | 14 of 21 names now versus roughly half last cycle — the direction of travel matters more than any single week |
| ESLT's next print | Largest single-cycle RSI move in the book (+11.5) with no confirmed cause on file |
| TDY, LMT, ITA's alpha1y | All three still show a positive headline 1-year return masking negative alpha — the earlier-stage version of what the rest of the book already shows in full |
Sources
- Tape data (price/RSI/SMA/returns/1-year, SMA200, volume): full-scan pre-computed summaries as of the 2026-09-11 close — drone-defense.
- AVAV Q1 FY27 results: news receipt fetched 2026-09-11 (Benzinga, "Why Is AeroVironment Stock Soaring Thursday?", 2026-09-10).
- PL Q2 results and Q3 guidance: news receipt fetched 2026-09-11 (Yahoo Finance recap of soft Q3 guidance and analyst price-target cut; earnings-call highlights, 2026-09-04).
- DFEN removal: watchlist changelog, 2026-09-08 (leveraged/inverse-ETF avoid policy).
Related
10 eventsNo direct external sources are attached to this read.